📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Graves' disease: developments in first-line antithyroid drugs in the young. (2020)

First Author: Lane LC

Attributed to: Molecular determinants of immune tolerance in Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/17446651.2020.1735359

PubMed Identifier: 32133893

Publication URI: http://europepmc.org/abstract/MED/32133893

Type: Journal Article/Review

Volume: 15

Parent Publication: Expert review of endocrinology & metabolism

Issue: 2

ISSN: 1744-6651